Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is different in children compared to in adults: a study of UK and Dutch clinical cohorts. — CFSMEATLAS
Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is different in children compared to in adults: a study of UK and Dutch clinical cohorts.
Collin, Simon M, Nuevo, Roberto, van de Putte, Elise M et al. · BMJ open · 2015 · DOI
Quick Summary
This study compared how ME/CFS affects children, teenagers, and adults by looking at patient data from clinics in the UK and a trial in the Netherlands. The researchers found that ME/CFS looks quite different depending on age: younger children were more likely to have sore throats and less likely to have problems with thinking or memory, while teenagers were more prone to headaches and depression. Adults showed more severe fatigue and disability overall.
Why It Matters
Understanding that ME/CFS presents differently in children versus adolescents versus adults is critical for accurate diagnosis and appropriate clinical management. This study helps pediatricians recognize disease patterns specific to younger patients, potentially reducing diagnostic delays and improving care strategies tailored to each age group.
Observed Findings
Younger children (<12 years) had more equal gender distribution and were less likely to have cognitive symptoms (OR 0.18) but more likely to present with sore throat (OR 1.42) compared to adults.
Adolescents (12-18 years) had significantly higher headache prevalence (81.1%) and were more likely to have comorbid depression (OR 1.51) but less likely to have anxiety (OR 0.46) compared to adults.
Adults demonstrated greater overall disability, fatigue severity, and longer illness duration compared to both child and adolescent groups.
Adolescents were less likely than adults to experience tender lymph nodes, palpitations, dizziness, and general malaise.
Inferred Conclusions
ME/CFS presents with distinct clinical phenotypes across developmental stages, requiring age-specific diagnostic and management approaches in pediatric settings.
The symptom profile differences may reflect underlying developmental, biological, or disease progression factors that warrant further investigation.
Pediatricians should be trained to recognize pediatric-specific presentations (sore throat prominence, reduced cognitive symptoms in young children) to avoid diagnostic misattribution.
Remaining Questions
Do the observed age-related symptom differences reflect distinct biological mechanisms or stages of the same disease process?
What explains the shift in comorbidity patterns, particularly the higher depression and lower anxiety in adolescents compared to adults?
What This Study Does Not Prove
This study does not prove what causes the age-related differences in ME/CFS presentation or whether they reflect different underlying biological mechanisms. It is observational data showing associations, not experimental evidence, and cannot establish whether these differences result from developmental factors, disease progression, or other unmeasured variables. The secondary analysis nature of parts of this work also means some findings require independent confirmation.
How do developmental factors (immune maturation, neurological development, hormonal changes) contribute to the different clinical presentations across age groups?
Do these phenotypic differences predict different treatment responses or long-term outcomes in children, adolescents, and adults?